Although multicenter clinical trials and meta-analysis testing exogenous EPO in premature infants did not find evidence of neuroprotection or worsened severity of ROP [21,22,23], another study suggests that EPO is beneficial to the preterm infant without affecting ROP [24]. Here, EPO is linked to retinopathy of prematurity.